Capstone Therapeutics Corp (CAPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,816 | 2,291 | 805 | 1,275 | 1,718 |
| TOTAL | $1,884 | $2,302 | $881 | $1,373 | $1,802 |
| Non-Current Assets | |||||
| Intangibles | 78 | 118 | 157 | 196 | 235 |
| TOTAL | $78 | $118 | $157 | $196 | $235 |
| Total Assets | $1,962 | $2,420 | $1,038 | $1,569 | $2,037 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 415 | 244 | 203 | 197 | 157 |
| TOTAL | $417 | $247 | $206 | $199 | $193 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,415 | 2,355 | 2,296 | 2,249 | 2,159 |
| TOTAL | $2,415 | $2,355 | $2,296 | $2,249 | $2,159 |
| Total Liabilities | $2,832 | $2,602 | $2,502 | $2,448 | $2,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54 | 54 | 54 | 54 | 54 |
| Common Shares | 27 | 27 | 27 | 27 | 27 |
| Retained earnings | -191,376 | -190,683 | -191,961 | -191,374 | -190,810 |
| TOTAL | $-870 | $-182 | $-1,464 | $-879 | $-315 |
| Total Liabilities And Equity | $1,962 | $2,420 | $1,038 | $1,569 | $2,037 |